Suchergebnisse - "Sarilumab"

PubPharm (130)

21

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

22

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

23

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison

enthalten in: Rheumatology and therapy | 2023

von Huizinga, T. | Choy, E. | Praestgaard, A. | +8

24

Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Gallagher, J. | Morgan, R.

CommentOn: Clin Microbiol Infect. 2023 Jan;29(1):13-21. - PMID 35863630

25

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids : a systematic review and meta-analysis

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2023

von Albuquerque, A. | Eckert, I. | Tramujas, L. | +4

CommentIn: Clin Microbiol Infect. 2023 Jan;29(1):7-9. - PMID 36257548

26

A comparison of the effectiveness of different doses of tocilizumab and sarilumab in the treatment of severe COVID-19: a natural experiment due to drug shortages

in: International Journal of Infectious Diseases | 2023

von Maaike C. Swets | Rob J. Moss | Flip Kor | +10

27

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

in: Arthritis Research & Therapy | 2023

von Wolfgang A. Schmidt | Bhaskar Dasgupta | Jennifer Sloane | +13

28

Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis

in: Arthritis Research & Therapy | 2023

von Luis Sainz | Pau Riera | Patricia Moya | +7

29

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5

30

Drug-induced liver injury following the use of tocilizumab or sarilumab in patients with coronavirus disease 2019

enthalten in: BMC infectious diseases | 2022

von Gao, Q. | Yin, X. | Tan, B. | +5